As of 2025-07-07, the EV/EBITDA ratio of Vascular Biogenics Ltd (VBLT) is 0.76. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. VBLT's latest enterprise value is -12.15 mil USD. VBLT's TTM EBITDA according to its financial statements is -15.94 mil USD. Dividing these 2 quantities gives us the above VBLT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.2x - 12.4x | 12.3x |
| Forward P/E multiples | 13.8x - 14.3x | 14.0x |
| Fair Price | (2.52) - (2.23) | (2.39) |
| Upside | -1713.4% - -1529.2% | -1633.8% |
| Date | EV/EBITDA |